Skip to main content
Caplight Logo









T-Heart

T-Heart

Private
ParisHealthcare & Life Scienceshttps://theartvalve.com/

Company Overview

T-Heart operates in Healthcare & Life Sciences and is based in Paris. It was founded in 2018.

T-Heart is a medical device company developing a novel transcatheter prosthetic heart valve for the treatment of tricuspid regurgitation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

T-Heart Comparables

Compare T-Heart with similar companies based on industry and business-model similarity.

T-Heart comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
VDyne
93%
Trisol Medical
91%
Laplace Interventional
89%
Book a demo to see all comparables

For institutional investors. Book with your work email.

T-Heart Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for T-Heart. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

T-Heart Investors

Notable investors and investment history

T-Heart investors
InvestorRounds
iBionextSeed, Series A

T-Heart Filings

Explore SEC and related filing metadata, where available.

T-Heart filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about T-Heart's valuation, stock price, and market status.

Is T-Heart a public or private company?

T-Heart is a private company.

What is the current stock price of T-Heart?

T-Heart is a private company, so its shares have no public market price. Caplight tracks T-Heart's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is T-Heart worth (valuation)?

Valuation information for T-Heart is not publicly available.

Can I buy T-Heart stock?

T-Heart shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was T-Heart's last funding round?

Funding round information for T-Heart is not publicly available.

Who are the main investors in T-Heart?

Key investors in T-Heart include iBionext.

Will T-Heart IPO soon?

No public IPO plans have been announced for T-Heart.

How can I track T-Heart secondary market activity?

Caplight tracks bids, offers, and trades in T-Heart's shares on secondary markets.

Firmographic Details

HeadquartersParis
Year Founded2018
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?